Author:
Tregellas Jason R,Olincy Ann,Johnson Lynn,Tanabe Jody,Shatti Shireen,Martin Laura F,Singel Debra,Du Yiping P,Soti Ferenc,Kem William R,Freedman Robert
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference21 articles.
1. Andreasen NC (1982). Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 39: 784–788.
2. Breese CR, Adams C, Logel J, Drebing C, Rollins Y, Barnhart M et al (1997). Comparison of the regional expression of nicotinic acetylcholine receptor α7 mRNA and [125I]-α-bungarotoxin binding in human postmortem brain. J Comp Neurol 387: 385–398.
3. Briggs CA, McKenna DG, Piattoni-Kaplan M (1995). Human alpha-7 nicotinic acetylcholine receptor responses to novel ligands. Neuropharmacology 34: 583–590.
4. De Fiebre CM, Meyer EM, Henry JC, Muraskin SI, Kem WR, Papke RL (1995). Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha-7/125 I-alpha-bungarotoxin receptor subtypes. Mol Pharmacol 47: 164–171.
5. Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R, Dunwiddie TV (1998). Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci 18: 1187–1195.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献